We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+25.19%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.52B
AUM Growth
+$762M
Cap. Flow
+$251M
Cap. Flow %
5.54%
Top 10 Hldgs %
32.69%
Holding
126
New
33
Increased
18
Reduced
34
Closed
36

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$104M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$86M
3
AGN
Allergan plc
AGN
+$83.3M
4
PFE icon
Pfizer
PFE
+$80.2M
5
PBYI icon
Puma Biotechnology
PBYI
+$79.5M

Top Sells

Rank Stock Value
1
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$145M
2
ABT icon
Abbott
ABT
+$82.8M
3
GDDY icon
GoDaddy
GDDY
+$79.9M
4
AERI
Aerie Pharmaceuticals
AERI
+$68.4M
5
BLK icon
Blackrock
BLK
+$65.5M

Sector Composition

Rank Sector Weight
1 Healthcare 54.61%
2 Technology 11.18%
3 Communication Services 3.96%
4 Consumer Discretionary 3.1%
5 Financials 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INTU icon
26
Intuit
INTU
$86.3B
$66M 1.46%
252,539
+3,356
+1% +$776K
ESPR
27
DELISTED
Esperion Therapeutics
ESPR
$65.3M 1.44%
1,627,079
-251,924
-13% -$11.3M
ALGN icon
28
Align Technology
ALGN
$12.4B
$60.5M 1.34%
212,889
-24,359
-10% -$5.81M
MMSI icon
29
Merit Medical Systems
MMSI
$4.97B
$60.4M 1.34%
977,313
+275,020
+39% +$15.6M
NYT icon
30
New York Times
NYT
$12.3B
$56.8M 1.25%
1,727,851
+918,150
+113% +$27.2M
PYPL icon
31
PayPal
PYPL
$49.3B
$52.7M 1.16%
507,599
-445,985
-47% -$42.2M
EXAS
32
DELISTED
Exact Sciences
EXAS
$49.1M 1.08%
+566,359
New +$48.2M
RVTY icon
33
Revvity
RVTY
$12.7B
$45.5M 1.01%
+472,656
New +$42.6M
NVRO
34
DELISTED
NEVRO CORP.
NVRO
$45.1M 1%
721,229
+165,134
+30% +$7.77M
XYZ
35
Block Inc
XYZ
$49.2B
$43.1M 0.95%
575,598
+46,558
+9% +$3.37M
PTCT icon
36
PTC Therapeutics
PTCT
$6.26B
$40.9M 0.9%
+1,086,776
New +$36.5M
IRTC icon
37
iRhythm Holdings
IRTC
$3.91B
$40.6M 0.9%
542,033
+126,214
+30% +$10.8M
IQV icon
38
IQVIA
IQV
$39.1B
$39.8M 0.88%
+276,809
New +$36.9M
HCA icon
39
HCA Healthcare
HCA
$85.7B
$37.4M 0.83%
286,951
-104,854
-27% -$14.1M
VYGR icon
40
Voyager Therapeutics
VYGR
$189M
$37.3M 0.83%
+1,951,061
New +$25.4M
AMZN icon
41
Amazon
AMZN
$2.53T
$35.8M 0.79%
402,400
-692,160
-63% -$57.6M
WVE icon
42
Wave Life Sciences
WVE
$1.11B
$35.1M 0.77%
+902,578
New +$36.6M
DERM
43
DELISTED
Dermira, Inc.
DERM
$35M 0.77%
+2,581,033
New +$21.5M
MSFT icon
44
Microsoft
MSFT
$3.35T
$34.9M 0.77%
296,300
-397,974
-57% -$43.4M
BABA icon
45
Alibaba
BABA
$279B
$33.2M 0.73%
182,212
+7,928
+5% +$1.33M
MSGS icon
46
Madison Square Garden
MSGS
$9.75B
$33.1M 0.73%
158,230
-42,630
-21% -$8.66M
LYV icon
47
Live Nation Entertainment
LYV
$42.7B
$32.7M 0.72%
514,407
+419,833
+444% +$23.8M
CRM icon
48
Salesforce
CRM
$148B
$32.5M 0.72%
205,398
-396,301
-66% -$61.4M
NXPI icon
49
NXP Semiconductors
NXPI
$61.8B
$31.9M 0.7%
+360,456
New +$31.7M
ALDR
50
DELISTED
Alder Biopharmaceuticals
ALDR
$31.5M 0.7%
+2,306,367
New +$29.9M
1
2
3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
AC
AWM Capital Phoenix, Arizona $1.1B AUM 15.03% 1-Year Est. Return

PFM Health Sciences's Q1 2019 Portfolio in Review

As of Q1 2019, PFM Health Sciences held 126 positions worth $4.52B, up 20% from $3.76B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

PFM Health Sciences deployed $251M of net new capital in Q1 2019, opening 33 new positions and adding to 18 existing holdings. Its largest new stake was Stryker: 579,444 shares worth $114M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 51% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Spark Therapeutics, Inc. Common Stock, an estimated $145M trimmed.

  • PFM Health Sciences's largest Q1 2019 buy was Stryker: 579,444 shares worth $114M.
  • PFM Health Sciences added most to Pfizer in Q1 2019, an estimated $80.2M increase.
  • PFM Health Sciences's biggest Q1 2019 reduction was Spark Therapeutics, Inc. Common Stock, cutting an estimated $145M.
  • PFM Health Sciences fully exited Abbott in Q1 2019, selling an estimated $82.8M.
  • PFM Health Sciences's ten largest holdings make up 33% of its $4.52B portfolio in Q1 2019.
  • PFM Health Sciences opened 33 new positions and closed 36 in Q1 2019.
  • PFM Health Sciences's portfolio value rose 20% quarter-over-quarter to $4.52B.

Based on PFM Health Sciences's 13F filing for Q1 2019, filed 15 May 2019.